LINC00511 and breast cancer: LINC00511 is dysregulated in multiple malignancies including glioma, BC, ovarian cancer, CC, osteosarcoma, HCC, lung cancer, TSCC, renal cell cancer, papillary thyroid carcinoma, pancreatic cancer, GC [77], and CRC [78].